37 results
DEFA14A
IOBT
IO Biotech Inc
24 Apr 24
Additional proxy soliciting materials
4:06pm
use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before … digit control number located in the box above available when you access the website and follow the instructions. Copyright © 2024 BetaNXT, Inc
8-K
EX-99.1
IOBT
IO Biotech Inc
8 Jan 24
Regulation FD Disclosure
8:11am
to treatment IOBT’s therapeutic cancer vaccine provides fast access to the medicine ensuring the patients don’t have to wait* … Enhancing the overall
8-K
EX-10.2
ky5306
7 Aug 23
IO Biotech, Inc. Announces $75 Million Private Placement Financing
8:31am
8-K
EX-10.1
qc9lum
7 Aug 23
IO Biotech, Inc. Announces $75 Million Private Placement Financing
8:31am
DEFA14A
fvpcnt8ojk2ramai
26 Apr 23
Additional proxy soliciting materials
4:07pm
PRE 14A
oeupvnmt3fef2j0wt
14 Apr 23
Preliminary proxy
4:39pm
DEFA14A
epwm7ziwr 319yao5
14 Apr 22
Additional proxy soliciting materials
4:04pm
DEF 14A
6ixfk0p
14 Apr 22
Definitive proxy
4:02pm
10-K
9022r4id dodj
31 Mar 22
Annual report
5:07pm
10-Q
EX-3.2
2h7 b67lvwq0
17 Dec 21
Quarterly report
4:55pm
10-Q
voks2wo9 4iaqmf
17 Dec 21
Quarterly report
4:55pm
8-K
EX-10.1
msbm40a1a 2csw
6 Dec 21
Entry into a Material Definitive Agreement
9:00am
424B4
txosvp4
8 Nov 21
Prospectus supplement with pricing info
5:20pm